Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2004 | 2 |
2008 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Laboratory capacity to detect antimicrobial resistance, 1998.
MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1167-71.
MMWR Morb Mortal Wkly Rep. 2000.
PMID: 11266245
Free article.
Emerging mechanisms of antimicrobial resistance have clinical, microbiologic, and infection-control implications for health-care providers. Antimicrobial resistant organisms include Staphylococcus aureus with reduced susceptibility to vancomycin (minimum inhibitory concent …
Emerging mechanisms of antimicrobial resistance have clinical, microbiologic, and infection-control implications for health-care prov …
Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC.
Jordan HT, et al.
Pediatr Infect Dis J. 2008 Dec;27(12):1057-64. doi: 10.1097/INF.0b013e318180b3b9.
Pediatr Infect Dis J. 2008.
PMID: 18989238
We describe trends in late-onset GBS over a 16-year period to characterize disease burden and estimate vaccine preventability. METHODS: We conducted active, population-based surveillance for invasive late-onset GBS disease in 10 states from 1990 to 2005. A case was …
We describe trends in late-onset GBS over a 16-year period to characterize disease burden and estimate vaccine preventability. METHODS: We c …
Item in Clipboard
Laboratory practices for prenatal group B streptococcal screening--seven states, 2003.
Centers for Disease Control and Prevention (CDC).
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2004 Jun 18;53(23):506-9.
MMWR Morb Mortal Wkly Rep. 2004.
PMID: 15201843
Free article.
In the United States, group B streptococcus (GBS) is the leading cause of serious bacterial infections in newborns. In 1996, consensus guidelines for use of intrapartum antibiotic prophylaxis (IAP) to prevent perinatal GBS disease recommended either of two methods f …
In the United States, group B streptococcus (GBS) is the leading cause of serious bacterial infections in newborns. In 1996, c …
Item in Clipboard
Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States, 2000-2003.
Centers for Disease Control and Prevention (CDC).
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2004 Jun 18;53(23):502-5.
MMWR Morb Mortal Wkly Rep. 2004.
PMID: 15201842
Free article.
This report updates early-onset incidence trends since 1999 analyzed by using population-based, multistate data from the Active Bacterial Core surveillance (ABCs)/Emerging Infections Program Network. ...
This report updates early-onset incidence trends since 1999 analyzed by using population-based, multistate data from the Active Ba …
Item in Clipboard
Cite
Cite